Trending...
- Mensa identifies best board games of 2025
- People & Stories/Gente y Cuentos Announces New Board Leadership & Corporate Partnership Initiative
- How to Fast-Track Your Way to the Top with The Code
FAYETTEVILLE, Ark. - OhioPen -- Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China. These patents strengthen Lineus Medical's intellectual property portfolio as the company continues expanding into major healthcare markets worldwide. They also mark a key milestone toward obtaining regulatory clearances and establishing distribution partnerships in these regions.
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on Ohio Pen
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on Ohio Pen
- New Podcast "Change Cycle" Unpacks the Complexity of Driving Systemic Change Toward a Circular Economy
- Rkaydz Video Game Museum Launches "Acquisition Series"
- GMS and PRO Software Partner to Deliver Cutting-Edge HR Solutions
- Coastguard Nelson (NZ) selects Omnitronics omnicore Express Dispatch - Completing their transition from analog to digital
- First Choice Neurology Partners with NeuroDiscovery AI to Advance Neurological Care and Research
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
Source: Lineus Medical
0 Comments
Latest on Ohio Pen
- $4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression, PTSD: NRx: Stock Symbol: NRXP
- Miami Valley Urban League Announces their 2025 Pillar Award Recipients
- YMCA Seeks to Expand Civic Leadership Opportunities for More New Jersey Youth
- Anern Launches New Generation of Lithium Solar Batteries, Empowering a Smarter, Greener Future
- K2 Integrity and the Institute for Financial Integrity Launch AML/CFT Course for Investment Advisers
- Buttcoin - The Next Bitcoin Foundation Explores First Spot Buttcoin ($BUTTCOIN) ETP Listing on Switzerland's SIX Exchange
- Start Dogecoin cloud mining with XY Miners and maximize your passive income
- William G. Chris of Businesslawyersohio.com Sets New Standard for Corporate Legal Excellence
- New Report Highlights the Most Dangerous States for Transportation and Warehouse Workers
- Seecoin Expands Beyond Gaming: A Web3 (r)evolution for All Content Creators
- Barcelona-based Neurosurgical Specialist Awarded Designation of International Center of Excellence for Ehlers Danlos Syndrome
- Pregis Expands Multi-Layer Technology for High-Performance Barrier Films at Anderson Facility
- New Professional Association to Study Principles of Hospitality Applied to the Delivery of Healthcare
- Marco's Pizza Foundation Makes Significant First Donation to Junior Achievement of $317,000
- Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
- Patricia Ann Cargill Charities selected for PGA tournament fundraiser, launches veterans walk team for BK5K on Father's Day
- Exclusive Content Licensing for Thought Leadership (B2B)
- Speaker and Author Matthew Cossolotto Launches Award-Winning The Joy of Public Speaking eBook as Part of His "Spread the Joy" Campaign
- HYSTER-YALE ANNOUNCES DATES OF FIRST QUARTER 2025 EARNINGS RELEASE AND WEBCAST
- Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads